Rhoda Sperling, MD
- PROFESSOR | Obstetrics, Gynecology and Reproductive Science
- PROFESSOR | Medicine, Infectious Diseases
Specialty:Obstetrics and Gynecology
Dr. Rhoda Sperling is a Professor in the Icahn School of Medicine at Mount Sinai, with a joint appointment in the Department of Obstetrics, Gynecology, and Reproductive Science as well as the Department of Medicine, Division of Medical ID. She is an internationally recognized expert in OBS-GYN infectious diseases.
Dr. Sperling's practice focuses on office gynecology, including menopause management; treatment and prevention of sexually transmitted infections; treatment and prevention of vulvo-vaginitis; and treatment and prevention of HPV-related diseases. She also is the director of the MSH-ObID clinic, which provides comprehensive care and case management services to women with HIV and other viral infections complicating pregnancy.
Dr. Sperling is an active member of the American College of Obstetricians and Gynecologists (ACOG) Immunization and Emerging Infections Expert Working Group (IEIEWG). This group addresses policy and practice issues related to adult immunization and OBS-GYN infectious diseases. She has contributed to numerous practice guidelines. Her research career has focused on two broad areas: strategies to reduce the risk of horizontal and vertical transmission of viral pathogens, as well as immunology and pregnancy.
Appointments by phone only at the 1176 5th Avenue Office
Obstetrics & Gynecology
- Genital Herpes
- HIV And AIDS
- Human Papillomavirus Testing
- Human Papillomavirus Vaccine
MD, University of Chicago
Residency, OB/GYN, Mount Sinai Hospital
Fellowship, Infectious Disease, City Hospital Center at Elmhurst
Fellowship, Infectious Disease, University of Texas Health Science
- The effect of non-ulcerative sexually transmitted infections on cervico-vaginal microbes and cervico-vaginal immune response
The purpose of this study is to understand the interplay between cervical infections with gonorrhea or chlamydia, changes in the normal vaginal microbiota, and alterations in local innate immune responses. Changes in immune responses could lead to an enhanced risk of a diverse...